Major depressive disorder (MDD) is a clinical condition defined by persistent low mood or loss of interest in activities that lasts at least two weeks and interferes with daily functioning. It goes well beyond ordinary sadness: the diagnosis requires a cluster of symptoms affecting sleep, energy, concentration, appetite, and self-worth, and it ranks among the leading causes of disability worldwide. What causes it turns out to be far more layered than any single “chemical imbalance” story suggests, involving genetics, stress biology, inflammation, brain connectivity, and life experience woven together in ways researchers are still untangling.
The Symptoms That Define the Diagnosis
The formal diagnostic criteria list nine possible symptoms, and a person must have at least five of them, present nearly every day for two weeks or more, to qualify for a diagnosis. At least one of those five has to be either persistent depressed mood or anhedonia, which is the loss of pleasure or interest in things you used to enjoy. The remaining symptoms include significant changes in appetite or weight, insomnia or sleeping too much, feeling physically slowed down or agitated, fatigue, feelings of worthlessness or excessive guilt, difficulty thinking or concentrating, and recurrent thoughts of death or suicide.
Research into which of these symptoms carry the most diagnostic weight has found that depressed mood is the single best symptom for distinguishing people who are not depressed from those with moderate depression. Anhedonia, meanwhile, is what best separates moderate depression from severe depression. Among the secondary criteria, physical symptoms like appetite and sleep changes tend to flag moderate cases, while psychological symptoms like worthlessness and concentration problems are more characteristic of severe ones.1PubMed Central. DSM-5 Criteria and Depression Severity: Implications for Clinical Practice
What this means in practice is that two people with the same diagnosis can look very different. One person might sleep fourteen hours a day, gain weight, and move through life in a fog. Another might lie awake at 3 a.m., lose their appetite entirely, and feel a restless agitation they can’t shake. Both meet the criteria. This heterogeneity is one of the things that makes MDD so challenging to study and treat.
Melancholic and Atypical Depression
Clinicians have long recognized that depression tends to cluster into subtypes, and the two most studied are melancholic and atypical depression. Melancholic depression is marked by a near-total loss of pleasure, worsening mood in the morning, early-morning waking, significant weight loss, and pronounced guilt. Atypical depression, somewhat confusingly named since it is quite common, features mood that temporarily lifts in response to good news, increased appetite and weight gain, heavy feelings in the limbs, oversleeping, and heightened sensitivity to rejection.
These subtypes are not just different on the surface. A study in the Netherlands found that people with chronic melancholic depression had overactive stress-hormone responses, while people with chronic atypical depression showed higher levels of inflammatory markers, higher body mass index, and disrupted cholesterol and triglyceride levels.2Molecular Psychiatry. Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression In other words, these subtypes appear to involve different biological pathways, not just different moods. That distinction has practical implications: a treatment that targets inflammation might help one group more than another, and a medication that blunts the stress response might be better suited to melancholic cases.
The Serotonin Story and Why It Is Incomplete
For decades, the popular explanation for depression was that it results from low serotonin levels in the brain. This idea, known as the monoamine hypothesis, grew out of observations that medications boosting serotonin, norepinephrine, or dopamine could relieve depressive symptoms. It was a tidy narrative, and it shaped how millions of people understood their own illness. But the evidence behind it has always been thinner than the public messaging suggested.
A landmark umbrella review published in Molecular Psychiatry examined the major areas of serotonin research and concluded that there is no consistent evidence linking low serotonin activity or concentration to depression.3Molecular Psychiatry. The serotonin theory of depression: a systematic umbrella review of the evidence Earlier work had already acknowledged this gap: while antidepressants that raise monoamine levels do help many patients, decades of research failed to find convincing evidence that a primary dysfunction in any specific monoamine system actually causes the disorder.4PubMed. Depression: the case for a monoamine deficiency
This does not mean serotonin is irrelevant to depression, or that antidepressants do not work. It means the “low serotonin” framing was always an oversimplification. Antidepressants change serotonin levels within hours, yet their mood effects take weeks. That delay suggests they are triggering downstream changes, possibly in how the brain rewires itself, rather than simply topping off a depleted tank. The cause of depression is not one broken molecule. It is a tangle of processes operating at different levels.
Stress Hormones and the Brain’s Alarm System
One of the most consistent biological findings in depression involves the body’s stress-response system, specifically the hypothalamic-pituitary-adrenal (HPA) axis. When you encounter a threat, this system releases cortisol to mobilize energy and sharpen focus. In a healthy person, the response shuts off once the threat passes. In many people with depression, it does not shut off properly. Prolonged HPA activation disrupts cortisol regulation and can damage brain regions involved in mood and memory.5PubMed Central. Chronic Stress-Associated Depressive Disorders: The Impact of HPA Axis Dysregulation and Neuroinflammation on the Hippocampus-A Mini Review
Early life stress appears to make this system especially vulnerable. A systematic review found that HPA axis abnormalities are associated with depressive pathology, and that early life stress has an independent effect on the axis, altering its function in ways that persist into adulthood. The review also noted that HPA hyperactivity in people with depression may dampen over time, but the negative feedback system that is supposed to rein cortisol in can remain impaired, particularly in people who experienced childhood adversity.6PubMed. The impact of early life stress on the hypothalamic-pituitary-adrenal axis in unipolar major depression: A systematic review
Closely related to the stress-hormone story is the role of a protein called brain-derived neurotrophic factor, or BDNF, which helps the brain form new connections, maintain existing ones, and support the birth of new neurons. Stress and depression are both associated with reduced BDNF activity, particularly in the prefrontal cortex and hippocampus, regions critical for emotional regulation and memory.7PubMed Central. The Role of BDNF on Neural Plasticity in Depression Antidepressants and exercise both appear to restore BDNF levels, which may help explain why they improve mood even though they work through very different mechanisms.8PubMed Central. Brain-Derived Neurotrophic Factor, Depression, and Physical Activity: Making the Neuroplastic Connection
The Genetic Picture
Depression runs in families, and twin studies have consistently shown a genetic contribution. But unlike, say, cystic fibrosis, there is no single “depression gene.” Instead, the genetic architecture of MDD involves many variants, each contributing a tiny amount of risk. Family, twin, and adoption studies confirm that genetic factors play a meaningful role, while also making clear that multiple genetic factors working alongside environmental factors are typically necessary for the disorder to develop.9PubMed Central. Overview of the genetics of major depressive disorder
Recent genome-wide studies have begun to put numbers on this. A large study using a clinically harmonized sample estimated that common genetic variants account for roughly 12 to 27 percent of the variation in depression risk, depending on the statistical method used. Polygenic scores derived from one cohort predicted depression in an independent population, and twin analyses showed that concordance for MDD increased with polygenic burden, meaning the more risk variants twins carried, the more likely both were to be affected.10PubMed Central. Genetics of major depressive disorder in a homogeneous population with uniform phenotyping
The practical takeaway: having a close relative with depression raises your own risk, but it does not determine your fate. The heritability estimates leave a large share of the picture shaped by environment, life experience, and their interaction with genes.
Stressful Life Events and the Kindling Effect
Stressful life events, things like job loss, divorce, bereavement, or financial crisis, have a strong causal relationship with the onset of depressive episodes. But research has also revealed a wrinkle: about a third of the statistical link between stressful events and depression is not purely causal. Instead, people who are predisposed to depression tend to select themselves into higher-risk environments, creating a feedback loop.11PubMed. Causal relationship between stressful life events and the onset of major depression
There is also a phenomenon sometimes called “kindling,” where the first episode of depression typically follows a clear stressor, but later episodes require less and less provocation. With each recurrence, the brain appears to become more sensitive to stress, and episodes can eventually arise with minimal or no identifiable trigger. This is one reason early treatment matters: preventing recurrence may help keep the brain from becoming progressively more vulnerable.
Childhood trauma adds another dimension. A twin study found that chemical modifications to genes involved in the stress response and brain plasticity, specifically the NR3C1 gene (related to cortisol signaling) and the BDNF gene, mediated roughly a fifth of the relationship between childhood trauma and later depressive symptoms.12PubMed Central. Childhood Trauma, DNA Methylation of Stress-related Genes, and Depression: Findings from Two Monozygotic Twin Studies These epigenetic changes do not alter the DNA sequence itself but affect how genes are read, offering a molecular pathway through which early adversity gets embedded in biology. The heritability of trauma-related conditions like depression is generally low to moderate and highly variable, consistent with a picture where gene-environment interactions play a central role.13PubMed Central. Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma
Inflammation and the Body’s Immune Response
One of the more surprising developments in depression research over the past two decades has been the discovery that the immune system is involved. Multiple studies have found elevated levels of inflammatory markers, including interleukin-6, tumor necrosis factor-alpha, and C-reactive protein, in the blood of people with major depression. Some research has also detected elevated inflammatory molecules in cerebrospinal fluid, with levels correlating with depression severity in certain studies.14PubMed Central. Inflammatory Cytokines in Depression: Neurobiological Mechanisms and Therapeutic Implications
Inflammation does not appear to be the whole story for everyone with depression, but it may be especially relevant for the atypical subtype, as noted in the Dutch study linking atypical depression to metabolic and inflammatory dysregulation. This has opened up interest in anti-inflammatory approaches to treatment, though that research is still in relatively early stages. It also helps explain why depression so often co-occurs with inflammatory medical conditions like autoimmune diseases and obesity.
Sleep, Circadian Rhythms, and Mood
Sleep problems are so common in depression that they are part of the diagnostic criteria, but the relationship between disturbed sleep and mood goes deeper than symptom overlap. People with MDD frequently show disrupted circadian rhythms, including irregular patterns of sleep, appetite, physical activity, and cortisol release.15PubMed. The role of the circadian system in the etiology of depression Many depressed people experience a characteristic daily pattern where mood is worst in the morning and gradually improves through the day, a rhythm tied to the body’s internal clock.
Genetic studies have identified variants in core clock genes, particularly CLOCK, CRY1, and TIMELESS, that correlate with both circadian disruption and susceptibility to MDD. Combined with evidence of abnormal melatonin signaling and HPA axis dysfunction, this has led some researchers to argue that circadian disruption may be a cause of depression rather than just a byproduct.16PubMed Central. Circadian rhythms in major depressive disorder: mechanistic insights and therapeutic frontiers Treatments that target circadian function, such as light therapy, sleep-wake scheduling, and the antidepressant agomelatine (which acts on melatonin receptors), lend some support to this idea.
Changes in Brain Connectivity
Brain imaging studies have repeatedly highlighted a network called the default mode network (DMN), a set of interconnected regions active when you are mind-wandering, reflecting on yourself, or ruminating. Early studies suggested that DMN connectivity was increased in depression, potentially explaining the hallmark tendency toward excessive self-focused, negative thinking. More recent large-scale work has complicated that picture.
A study pooling data from 848 patients with MDD and 794 controls across 17 sites found that DMN connectivity was actually reduced in depression, not increased. The reduction appeared only in people with recurrent depression, not in first-episode cases. Medication use was associated with decreased DMN connectivity, and in people with recurrent episodes, connectivity was positively related to symptom severity.17PubMed Central. Reduced default mode network functional connectivity in patients with recurrent major depressive disorder A separate study identified two distinct neuroimaging subtypes of MDD: one with reduced DMN connectivity and another with increased connectivity, each affecting roughly 60 and 40 percent of patients, respectively.18PubMed Central. Biotypes of major depressive disorder: Neuroimaging evidence from resting-state default mode network patterns
The existence of at least two brain-connectivity subtypes reinforces a broader theme: MDD is probably not one disease. It may be an umbrella that covers several distinct conditions sharing surface-level symptoms but differing in their underlying biology. That possibility has serious implications for treatment, because a therapy that works for one biological subtype might do little for another.
Depression and Heart Disease
Depression does not just affect your mental health. One of the most robust medical findings in this area is the bidirectional relationship between depression and cardiovascular disease (CVD). A large meta-analysis estimated that roughly one in five people with cardiovascular disease also has depression, with the rate rising to about one in four among those with heart failure.19Molecular Psychiatry. Cardiovascular diseases and depression: A meta-analysis and Mendelian randomization analysis Using a genetic technique called Mendelian randomization, which helps distinguish correlation from causation, the same analysis found evidence that the relationship runs in both directions: MDD increases the odds of developing coronary artery disease, myocardial infarction, and heart failure, and cardiovascular disease raises the likelihood of depression.
The mechanisms linking the two likely involve several of the pathways already discussed. Chronic stress-hormone activation raises blood pressure and promotes arterial damage. Inflammation contributes to both atherosclerosis and depressive symptoms. Behavioral factors matter too: depression saps motivation for exercise, healthy eating, and medication adherence. This overlap is one reason screening for depression in cardiac patients has become standard practice in many healthcare systems.
Why Depression Looks Different Across Cultures
The core features of depression, low mood, lost interest, disrupted sleep, and altered appetite, appear across cultures. But how people experience and describe those features varies considerably. In many cultures, depression is expressed primarily through physical complaints rather than emotional language. A study comparing Vietnamese and German psychiatric outpatients found that Vietnamese patients reported significantly higher levels of somatic symptoms, including pain, dizziness, and fainting spells, despite similar levels of depression severity.20PubMed. Cultural differences in symptom representation for depression and somatization measured by the PHQ between Vietnamese and German psychiatric outpatients
A cross-cultural factor analysis of depression symptoms across five broad cultural groups found both similarities and meaningful differences in how symptoms cluster together. In most groups, suicidal thoughts formed their own distinct cluster, but in the Latin American group, feelings of worthlessness loaded together with suicidality. Hypersomnia tended to group with psychomotor agitation across cultures, and appetite and weight changes sometimes clustered together but often did not.21PubMed. Factor analysis of depression symptoms across five broad cultural groups When clinicians are unfamiliar with culture-specific expressions of distress, depression can go unrecognized or be misidentified, sometimes leading to unnecessary medical workups for physical complaints that are actually driven by underlying mood problems.22PubMed. Cultural variations in the clinical presentation of depression and anxiety: implications for diagnosis and treatment
The Sex Gap in Depression
Women are diagnosed with depression at roughly twice the rate of men, a gap that is one of the most consistent findings in psychiatric epidemiology. The divergence appears during early adolescence and persists through reproductive years, narrowing somewhat after menopause. Research points to both biological and social contributors. Hormonal fluctuations during puberty, menstruation, the postpartum period, and perimenopause all coincide with windows of increased vulnerability.23PubMed Central. Depression in Women: Potential Biological and Sociocultural Factors Driving the Sex Effect
But biology is only part of the explanation. Women face higher rates of sexual violence and intimate-partner abuse, bear a disproportionate caregiving burden, and in many societies experience chronic low social status, all established risk factors for depression. Men, meanwhile, may underreport depressive symptoms or express them through anger, substance use, and risk-taking rather than sadness, leading to underdiagnosis. The true gap is probably real but smaller than the raw numbers suggest.
Why There Is No Blood Test for Depression
Despite decades of research into cortisol, inflammatory markers, BDNF, brain imaging patterns, and genetic risk scores, there is currently no laboratory test that can diagnose depression. The diagnosis remains clinical, based on a patient’s reported symptoms and a clinician’s evaluation.24PubMed Central. Suggested Biomarkers for Major Depressive Disorder This is not for lack of trying. The problem is that no single biomarker reliably distinguishes depressed people from non-depressed people across the full spectrum of the disorder. Cortisol is elevated in some patients but not others. Inflammatory markers are high in some subtypes but normal in others. Brain imaging can identify group-level differences but cannot yet diagnose an individual.
The search for biomarkers continues, driven partly by the hope that biological subtypes could be matched to specific treatments, a precision-medicine approach that has transformed oncology but has so far eluded psychiatry. In the meantime, the most useful diagnostic tools remain a careful clinical interview and validated symptom questionnaires, imperfect instruments for a disorder whose biology is genuinely plural.
The Gut-Brain Connection
An emerging area of research focuses on the gut microbiome, the trillions of bacteria living in the digestive tract, and its potential influence on mood. The gut-brain axis is a bidirectional communication system linking intestinal function to the central nervous system. According to the gut microbiota hypothesis, changes in the composition and activity of gut bacteria can affect this axis and contribute to the onset of mental illnesses including depression.25The Ukrainian Biochemical Journal. Major depressive disorder and the microbiome-gut-brain axis The proposed mechanisms include altered production of neurotransmitters by gut bacteria, changes in intestinal permeability that allow inflammatory molecules into the bloodstream, and direct signaling through the vagus nerve.
The field is still young, and most evidence comes from animal studies or small human trials. Probiotic supplementation has shown modest effects on depressive symptoms in some studies but not others. The gut-brain connection is unlikely to be the primary driver of depression for most people, but it may turn out to be one more thread in the web of biological processes that makes some people vulnerable. For now, the practical advice is limited: a varied diet rich in fiber appears to support a healthy microbiome, and that dietary pattern also happens to be associated with lower depression risk in observational studies, though proving cause and effect remains difficult.
Is Depression an Evolutionary Adaptation?
Researchers have debated whether our capacity for depressed mood might have served some purpose in our evolutionary past. One proposal, the analytical rumination hypothesis, suggests that depression evolved as a mechanism to keep people focused on complex social problems until they could work through them, somewhat like how pain keeps you from using an injured limb.26PubMed. Evolutionary theory and the treatment of depression: It is all about the squids and the sea bass A related framework proposes that depressed mood is an adaptive response to perceived threats of social exclusion, minimizing the risk of unpredictable interpersonal encounters.27Trends in Cognitive Sciences. Bridging Epistemic and Social Demands: A Free-Energy Formulation of Depressed Mood
Critics point out that while withdrawal from a hostile environment may be useful in the short term, clinical depression as a whole does not meet the standard criteria for a trait shaped by natural selection. It reduces reproductive fitness, it does not reliably help the affected individual survive, and its severity and duration are far beyond what any short-term adaptive function could justify.28PubMed Central. Is depression “evolutionary” or just “adaptive”? A comment. The emerging consensus, if there is one, is that a mild, temporary capacity for low mood may be adaptive in certain contexts, but the severe, recurring, life-threatening condition we call major depressive disorder almost certainly is not. Confusing the two can lead to the harmful implication that depressed people just need to “think through their problems” and will recover on their own.